New York, USA, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Prebiotics Ingredients Global Market to Observe Impressive Growth at a CAGR of ~10% by 2028 | DelveInsight
The prebiotic ingredients market is experiencing noteworthy growth, propelled by various factors such as the increasing demand for prebiotics as a key dietary supplement ingredient. Furthermore, the surge in consumer spending on healthcare products, driven by growing health concerns among the younger population, and the rising incidence of lactose intolerance, gastric spasm, flatulence, nausea, gas diarrhea, and other digestive disorders, contribute significantly to this remarkable market expansion.
DelveInsight’s Prebiotics Ingredients Market Insights report provides the current and forecast market analysis, individual leading prebiotics ingredients companies’ market shares, challenges, prebiotics ingredients market drivers, barriers, trends, and key market prebiotics ingredients companies in the market.
Key Takeaways from the Prebiotics Ingredients Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global prebiotics ingredients market during the forecast period.
- Notable prebiotics ingredients companies such as BENEO, Jarrow Formulas, Inc., Sensus (Cosun), COSUCRA., Nexira, Yakult Pharmaceutical Industry Co., Ltd., Prenexus Health., Cargill, Incorporated, FrieslandCampina Ingredients, Ingredion., Tereos SA, Dow, Kerry Group plc., Roquette Frères., Fonterra Co-Operative Group Limited, AIDP, SAMYANG HOLDINGS CORPORATION, Thera-Plantes Inc., Taiyo International, SOLACTIS, and several others, are currently operating in the prebiotics ingredients market.
- In June 2022, FrieslandCampina Ingredients, a global functional ingredient supplier, announced the latest launch of a product under its Biotis brand, Biotis GOS-OP High Purity. FrieslandCampina Ingredients specifically developed the prebiotic to drive innovation in the growing gut health supplements market. Boasting a galactooligosaccharides (GOS) content of over 90%, Biotis GOS-OP High Purity is the company’s purest prebiotic ingredient.
- In October 2021, OptiBiotix Health PLC launched SnackSmart Fruit & Fibre gummies, the first consumer-facing product in the company’s online store to contain the functional fiber and mineral blend, WellBiome, which promotes a healthy gut via a blend of non-digestible prebiotics and dietary fiber, glucomannan, and chromium.
To read more about the latest highlights related to the prebiotics ingredients market, get a snapshot of the key highlights entailed in the Global Prebiotics Ingredients Market Report
Prebiotics Ingredients Overview
Prebiotics are non-digestible fibers and compounds that promote the growth and activity of beneficial bacteria in the digestive system. These specialized ingredients serve as a nutritional substrate for the probiotic microorganisms, primarily the friendly bacteria residing in the gut. Unlike probiotics, which are live bacteria, prebiotics are essentially food for these beneficial microbes. Common examples of prebiotic ingredients include inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS), among others. These substances are found in various foods such as certain fruits, vegetables, and whole grains. The consumption of prebiotics has been associated with numerous health benefits, including improved gut health, enhanced immune function, and the potential to prevent certain diseases. As our understanding of the gut microbiome continues to evolve, prebiotics play a crucial role in supporting the balance and diversity of beneficial bacteria in the digestive system, contributing to overall well-being.
Prebiotics Ingredients Market Insights
In the global prebiotic ingredients market, North America is poised to claim the largest share, a trend expected to persist from 2023 to 2028. This dominance can be attributed to escalating demand driven by the region’s increasing prevalence of gastrointestinal disorders. Factors such as a surge in prebiotic ingredient launches, a rising preference for fortified foods among consumers, a flurry of ingredient launches, and more collectively contribute to the flourishing prebiotic ingredients market in North America. Additionally, the concentration of major players, including Dow Inc. and Ashland Global Holdings Inc., in the United States is anticipated to drive production, manufacturing, and overall demand for prebiotic ingredients.
To know more about why North America is leading the market growth in the prebiotics ingredients market, get a snapshot of the Prebiotics Ingredients Market Outlook
Prebiotics Ingredients Market Dynamics
The prebiotics ingredients market is experiencing significant growth driven by several factors. These include the increasing prevalence of gastrointestinal tract diseases such as constipation, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease (GERD), inflammatory bowel disease, and similar conditions on a global scale. According to the assessment done by DelveInsight, the estimated total prevalent irritable bowel syndrome cases in the 7MM were approximately 31 million in 2022.
Additionally, the expansion of cultivation and harvesting of natural herbs rich in prebiotics is anticipated to be a key driver for prebiotics ingredients market growth. The heightened investment in research and development (R&D) by industry players aiming to innovate and introduce new ingredients, coupled with a growing consumer willingness to invest in premium-priced food products featuring prebiotic elements for active health management, has empowered manufacturers to spearhead initiatives in this space. Furthermore, strategic initiatives undertaken by key players have contributed to a surge in demand for prebiotic ingredients in the market.
Nevertheless, it is crucial to note that challenges such as complications associated with excessive prebiotic consumption, elevated manufacturing costs, and other potential impediments may pose obstacles to the sustained growth of the prebiotic ingredients market throughout the forecast period (2023–2028).
Get a sneak peek at the prebiotics ingredients market dynamics @ Prebiotics Ingredients Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2020–2028 |
| Prebiotics Ingredients Market CAGR | ~10% |
| Key Prebiotics Ingredients Companies | BENEO, Jarrow Formulas, Inc., Sensus (Cosun), COSUCRA., Nexira, Yakult Pharmaceutical Industry Co., Ltd., Prenexus Health., Cargill, Incorporated, FrieslandCampina Ingredients, Ingredion., Tereos SA, Dow, Kerry Group plc., Roquette Frères., Fonterra Co-Operative Group Limited, AIDP, SAMYANG HOLDINGS CORPORATION, Thera-Plantes Inc., Taiyo International, SOLACTIS, among others |
Prebiotics Ingredients Market Assessment
- Prebiotics Ingredients Market Segmentation
- Prebiotics Ingredients Market Segmentation By Type: Inulin, Fructo-Oligosaccharide (FOS), Galacto-Oligosaccharide (GOS), and Others
- Prebiotics Ingredients Market Segmentation By Application: Infant Formula, Fortified Food And Beverage, Dietary Supplements, Animal Feed, and Others
- Prebiotics Ingredients Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the prebiotics ingredients market are set to emerge as the trendsetter explore @ Prebiotics Ingredients Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Prebiotics Ingredients Market |
| 7 | Prebiotics Ingredients Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Prebiotics Ingredients Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the prebiotics ingredients market by 2028? Click to get a snapshot of the Prebiotics Ingredients Market Trends
Related Reports
Irritable Bowel Syndrome Market
Irritable Bowel Syndrome Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key IBS companies, including Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical Sciences, Serentrix LLC, Vitality Biopharma, among others.
Irritable Bowel Syndrome Pipeline
Irritable Bowel Syndrome Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key irritable bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical Sciences, Serentrix LLC, Vitality Biopharma, among others.
Gastroesophageal Reflux Disease Market
Gastroesophageal Reflux Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key GERD companies, including Phathom Pharmaceuticals, Inc., Microbiome Health Sciences, Takeda, Braintree Laboratories, AstraZeneca, among others.
Gastroesophageal Reflux Disease Pipeline
Gastroesophageal Reflux Disease Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key GERD companies, including Cinclus Pharma, Onconic Therapeutics, Renexxion, Addpharma, Trio Medicines, Chong Kun Dang Pharmaceutical, HK inno.N Corporation, among others.
Gastroesophageal Reflux Disease Treatment Devices Market
Gastroesophageal Reflux Disease Market Insights, Competitive Landscape, and Market Forecast – 2028 report deliver an in-depth understanding of the disease as well as the market trends, market drivers, market barriers, and key GERD treatment devices companies, including Johnson & Johnson (Ethicon), EndoGastric Solutions, Medtronic, Olympus, Karl Storz, Fujifilm Holdings, Hoya Corporation, MediGus Ltd, Mederi-RF, LABORIE, PENTAX Medical, Diversatek Inc., among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
